| 1 |
Gerasimenko et al., 2015 65
|
5 |
NA |
|
|
|
|
Pulse mode: Train
Frequency: Carrier10 kHz; T11 – T12; 5 Hz Coccyx
Pulse width: 1 μs (monophasic)
Intensity: 80–180 mA (induce stepping movement at supramotor and voluntary stepping at submotor threshold)
|
|
|
| 2 |
Hofstoetter et al., 2015 68
|
3 |
D; C5-T9 |
|
|
|
|
|
|
|
| 3 |
Minassian et al., 2016 69
|
4 |
A; C8-T8 |
|
|
|
|
Pulse mode: Continuous
Frequency: 30 Hz
Pulse width: single, paired, and continuous
Intensity:100–170 mA – motor threshold
|
|
|
| 4 |
Powell et al., 2016 70
|
6 |
4C, 2D; C6-L1 |
|
|
|
|
Frequency: Not reported
Pulse mode: Continuous
Intensity: 2.5 mA
|
Intervention consisted of 3 sessions, separated by at least 1 week, in which each subject received the conditions cathodal, anodal, and sham TSCS
|
|
| 5 |
Gad et al., 2017 71
|
1 |
A; T9 |
|
Ambulation
Increased patient generation of level of effort, improved coordination patterns of the lower limb muscles, smoother stepping motion, increased blood pressure and heart rate
|
|
|
|
7 weeks training, 60-min, 4 weeks baseline training, 1-week TSCS, 1-week pharmacological, 1-week, & 1-week TSCS/pharmacological
|
|
| 6 |
Powell et al., 2018 72
|
6 |
4C, 2D; C6-L1 |
|
|
|
|
Pulse mode: Continuous
Frequency: Not reported
Intensity: 2.5 mA
|
Intervention consisted of 3 sessions, separated by at least 1 week, in which each subject received the conditions cathodal, anodal, and sham TSCS.
|
|
| 7 |
Rath et al., 2018 73
|
8 |
6A, 2C; C4-T9 |
|
|
|
|
|
|
|
| 8 |
Sayenko et al., 2019 74
|
15 |
11A, 1B, 3C; C4-T12 |
|
|
|
|
|
|
|
| 9 |
Meyer et al., 2020 75
|
10 |
D; C3-T10 |
|
Motor recovery
mmediate significant improvements in ankle motility were observed at 30 Hz, with suppression of pathological activity, assessed by polysynaptic spinal reflex. Non-significant improvements in walking speed were also observed.
|
|
|
Pulse mode: Train
Frequency: 15, 30 & 50 Hz
Pulse width: 1 μs (monophasic)
Intensity: 15–70 mA, Highest level comfortably tolerated
|
|
|
| 10 |
Shapkova et al., 2020 76
|
19 |
12A, 4B, 3C; C5-T12 |
|
Ambulation
Exoskeleton walk training with stimulation improved weight loading capacity and decreased gait asymmetry. Higher frequencies (67 Hz) had an antispasticity effect allowing independent walking. Subjects reported changes in proprioception, sensation, and paresthesias while walking with TSCS.
|
|
|
|
|
|
| 11 |
Wiesener et al., 2020 77
|
2 |
A; T5-T6 |
|
|
|
|
|
|
|
| 12 |
McHugh et al., 2020 78
|
10 |
4C, 6D; C4-T9 |
|
Ambulation
Subjects demonstrated significant improvements in walking speed, endurance, and quality following 8 weeks of training. No subjects reported pain with stimulation. Some subjects reported improvement in bowel, bladder, and pain markers.
|
|
|
|
|
|
|
|
| 1 |
Gad et al., 2018 79
|
6 |
2B, 4C; C4–C8 |
|
|
|
|
Pulse mode: Continuous
Frequency: 30 Hz, carrier 10 kHz
Pulse width: 1 μs (biphasic or monophasic)
Intensity: 70–180 mA (maximize handgrip)
|
|
|
| 2 |
Inanici et al., 2018 66
|
1 |
D; C3-4 |
|
Upper extremity function
Graded Redefined Assessment of Strength, Sensation, and Prehension
(GRASSP) test score increased 52 points and upper extremity motor score improved 10 points. Sensation recovered on trunk dermatomes, and overall neurologic level of injury improved from C3 to C4.
|
|
|
|
2 weeks baseline, 90 min sessions, 4–5 days/week, 9 weeks (4 weeks therapy and TSCS, 4 weeks therapy only, 1 week therapy and TSCS), 3 month follow up
|
|
| 3 |
Inanici et al., 2021 80
|
6 |
2B, 2C, 2D; C3–C5 |
|
|
|
|
Pulse mode: Continuous
Frequency: 30 Hz, carrier 10 kHz
Pulse width: 1 μs (biphasic and monophasic)
Intensity: 40–90 mA, sub motor threshold
|
4 weekly baseline assessments, 4 weeks task training, up to 120-min stimulation, 3 sessions/week, 4 weeks (12 sessions) 3 months follow up
|
|
| 4 |
Zhang et al., 2020 81
|
1 |
A; C5 |
|
|
Transcutaneous Electrical Spinal Cord Stimulator (NeuroRecovery
Technologies Inc., CA, USA).
|
|
|
1-week baseline, 60-min stimulation, 2–3 sessions/week,
8 weeks (18 sessions), 3-month follow-up once per month
|
|